Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling
The Pharmacogenomics Journal, Published online: 15 February 2021; doi:10.1038/s41397-021-00211-1Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 15, 2021 Category: Drugs & Pharmacology Authors: John Young Kaustuv Bhattacharya Sujith Ramachandran Aaron Lee John P. Bentley Source Type: research
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer
The Pharmacogenomics Journal, Published online: 04 February 2021; doi:10.1038/s41397-021-00207-xClinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2021 Category: Drugs & Pharmacology Authors: Mitsukuni Suenaga Marta Schirripa Shu Cao Wu Zhang Chiara Cremolini Sara Lonardi Satoshi Okazaki Martin D. Berger Yuji Miyamoto Shivani Soni Afsaneh Barzi Toshiharu Yamaguchi Fotios Loupakis Alfredo Falcone Heinz-Josef Lenz Source Type: research
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
The Pharmacogenomics Journal, Published online: 04 February 2021; doi:10.1038/s41397-021-00209-9Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - February 4, 2021 Category: Drugs & Pharmacology Authors: Osama A. Badary Source Type: research
Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
The Pharmacogenomics Journal, Published online: 18 January 2021; doi:10.1038/s41397-020-00205-5Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 18, 2021 Category: Drugs & Pharmacology Authors: Xiao Chen Fei Shen Nina Gonzaludo Alka Malhotra Cande Rogert Ryan J. Taft David R. Bentley Michael A. Eberle Source Type: research
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel
The Pharmacogenomics Journal, Published online: 18 January 2021; doi:10.1038/s41397-020-00203-7Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 18, 2021 Category: Drugs & Pharmacology Authors: Caterina Vivaldi Stefania Crucitta Silvia Catanese Federico Cucchiara Elena Arrigoni Irene Pecora Eleonora Rofi Lorenzo Fornaro Francesca Salani Valentina Massa Enrico Vasile Riccardo Morganti Romano Danesi Marzia Del Re Source Type: research
Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore
The Pharmacogenomics Journal, Published online: 18 January 2021; doi:10.1038/s41397-020-00204-6Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - January 18, 2021 Category: Drugs & Pharmacology Authors: Ji Heon Kim Doreen Su-Yin Tan Mark Yan Yee Chan Source Type: research
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
The Pharmacogenomics Journal, Published online: 15 December 2020; doi:10.1038/s41397-020-00202-8Does the RAAS play a role in loss of taste and smell during COVID-19 infections? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - December 15, 2020 Category: Drugs & Pharmacology Authors: Heloise R. Luchiari Ricardo J. Giordano Richard L. Sidman Renata Pasqualini Wadih Arap Source Type: research
Rapid response to the alpha-1 adrenergic agent phenylephrine in the perioperative period is impacted by genomics and ancestry
The Pharmacogenomics Journal, Published online: 10 November 2020; doi:10.1038/s41397-020-00194-5Rapid response to the alpha-1 adrenergic agent phenylephrine in the perioperative period is impacted by genomics and ancestry (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 10, 2020 Category: Drugs & Pharmacology Authors: Stephane Wenric Janina M. Jeff Thomas Joseph Muh-Ching Yee Gillian M. Belbin Aniwaa Owusu Obeng Stephen B. Ellis Erwin P. Bottinger Omri Gottesman Matthew A. Levin Eimear E. Kenny Source Type: research
Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients
The Pharmacogenomics Journal, Published online: 07 November 2020; doi:10.1038/s41397-020-00201-9Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 7, 2020 Category: Drugs & Pharmacology Authors: Val éria Tavares Ricardo Pinto Joana Assis Sara Coelho Mariana Brand ão Sara Alves Deolinda Pereira Rui Medeiros Source Type: research
A review of the existing literature on buprenorphine pharmacogenomics
The Pharmacogenomics Journal, Published online: 05 November 2020; doi:10.1038/s41397-020-00198-1A review of the existing literature on buprenorphine pharmacogenomics (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 5, 2020 Category: Drugs & Pharmacology Authors: Christopher W. Meaden Alexander Mozeika Rijul Asri Cynthia D. Santos Source Type: research
Population impact of pharmacogenetic tests in admixed populations across the Americas
The Pharmacogenomics Journal, Published online: 27 October 2020; doi:10.1038/s41397-020-00200-wPopulation impact of pharmacogenetic tests in admixed populations across the Americas (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 27, 2020 Category: Drugs & Pharmacology Authors: Guilherme Suarez-Kurtz Source Type: research
The Pharmacogenomics Journal: there is a new chief in town
The Pharmacogenomics Journal, Published online: 26 October 2020; doi:10.1038/s41397-020-00199-0The Pharmacogenomics Journal: there is a new chief in town (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 26, 2020 Category: Drugs & Pharmacology Authors: George P. Patrinos Source Type: research
Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis
The Pharmacogenomics Journal, Published online: 23 October 2020; doi:10.1038/s41397-020-00197-2Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 23, 2020 Category: Drugs & Pharmacology Authors: Yuan-sheng Wan Xue-jia Zhai Hong-ai Tan You-sheng Ai Li-bo Zhao Source Type: research
Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications
The Pharmacogenomics Journal, Published online: 20 October 2020; doi:10.1038/s41397-020-00196-3Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 20, 2020 Category: Drugs & Pharmacology Authors: Mohitosh Biswas Source Type: research
Pharmacogenetic information in Swiss drug labels – a systematic analysis
The Pharmacogenomics Journal, Published online: 17 October 2020; doi:10.1038/s41397-020-00195-4Pharmacogenetic information in Swiss drug labels – a systematic analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 17, 2020 Category: Drugs & Pharmacology Authors: C. Jeiziner K. Suter U. Wernli J. M. Barbarino L. Gong M. Whirl-Carrillo T. E. Klein T. D. Szucs K. E. Hersberger H. E. Meyer zu Schwabedissen Source Type: research
